PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $75,000 | -7.4% | 23,905 | -13.9% | 0.00% | – |
| Q2 2020 | $81,000 | -12.9% | 27,771 | -15.4% | 0.00% | -100.0% |
| Q1 2020 | $93,000 | -14.7% | 32,822 | -2.7% | 0.00% | 0.0% |
| Q4 2019 | $109,000 | +45.3% | 33,735 | -2.6% | 0.00% | – |
| Q3 2019 | $75,000 | -36.4% | 34,619 | -7.9% | 0.00% | -100.0% |
| Q2 2019 | $118,000 | -21.3% | 37,570 | -7.0% | 0.00% | 0.0% |
| Q1 2019 | $150,000 | +18.1% | 40,398 | -7.4% | 0.00% | 0.0% |
| Q4 2018 | $127,000 | +4.1% | 43,638 | -5.9% | 0.00% | 0.0% |
| Q3 2018 | $122,000 | -31.1% | 46,369 | -38.7% | 0.00% | 0.0% |
| Q2 2018 | $177,000 | -22.0% | 75,687 | -2.1% | 0.00% | 0.0% |
| Q1 2018 | $227,000 | -14.3% | 77,347 | -19.9% | 0.00% | 0.0% |
| Q4 2017 | $265,000 | +15.2% | 96,587 | +42.7% | 0.00% | 0.0% |
| Q3 2017 | $230,000 | -29.0% | 67,703 | -48.4% | 0.00% | 0.0% |
| Q2 2017 | $324,000 | +157.1% | 131,224 | +136.8% | 0.00% | 0.0% |
| Q1 2017 | $126,000 | +14.5% | 55,423 | +15.3% | 0.00% | 0.0% |
| Q4 2016 | $110,000 | -79.6% | 48,087 | -70.1% | 0.00% | -66.7% |
| Q3 2016 | $539,000 | +377.0% | 160,903 | +345.7% | 0.00% | +200.0% |
| Q2 2016 | $113,000 | +15.3% | 36,100 | +23.2% | 0.00% | 0.0% |
| Q1 2016 | $98,000 | +11.4% | 29,291 | +17.2% | 0.00% | 0.0% |
| Q4 2015 | $88,000 | -29.6% | 24,997 | +0.7% | 0.00% | 0.0% |
| Q3 2015 | $125,000 | -8.8% | 24,821 | +16.7% | 0.00% | 0.0% |
| Q2 2015 | $137,000 | +7.9% | 21,273 | +18.2% | 0.00% | 0.0% |
| Q1 2015 | $127,000 | -0.8% | 18,000 | +8.4% | 0.00% | 0.0% |
| Q4 2014 | $128,000 | +8.5% | 16,600 | +5.0% | 0.00% | 0.0% |
| Q3 2014 | $118,000 | -42.4% | 15,804 | -25.2% | 0.00% | 0.0% |
| Q2 2014 | $205,000 | +27.3% | 21,131 | +9.0% | 0.00% | 0.0% |
| Q1 2014 | $161,000 | -18.7% | 19,392 | -17.2% | 0.00% | 0.0% |
| Q4 2013 | $198,000 | +120.0% | 23,433 | +106.8% | 0.00% | – |
| Q3 2013 | $90,000 | – | 11,329 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |